Cargando…

Intestinal microbiota composition in patients with amyotrophic lateral sclerosis: establishment of bacterial and archaeal communities analyses

BACKGROUND: Emerging evidences have indicated that the composition of gut microbiota was significantly influenced by central nervous system diseases. The digestion and metabolism disturbances of patients with amyotrophic lateral sclerosis (ALS) might be strongly associated with ALS; however, this ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Chao-Di, Zheng, Jie-Jiao, An, Bing-Chen, Huang, Hong-Fang, Tan, Zhou-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759115/
https://www.ncbi.nlm.nih.gov/pubmed/31306225
http://dx.doi.org/10.1097/CM9.0000000000000351
_version_ 1783453637370970112
author Zhai, Chao-Di
Zheng, Jie-Jiao
An, Bing-Chen
Huang, Hong-Fang
Tan, Zhou-Chun
author_facet Zhai, Chao-Di
Zheng, Jie-Jiao
An, Bing-Chen
Huang, Hong-Fang
Tan, Zhou-Chun
author_sort Zhai, Chao-Di
collection PubMed
description BACKGROUND: Emerging evidences have indicated that the composition of gut microbiota was significantly influenced by central nervous system diseases. The digestion and metabolism disturbances of patients with amyotrophic lateral sclerosis (ALS) might be strongly associated with ALS; however, this has rarely been evaluated in these populations. This study was to evaluate bacterial and archaeal composition of gut flora and the corresponding metabolism performance of these micro-organisms in fecal samples of patients with ALS. METHODS: A comparative study was performed on the intestinal microbiota from eight patients with ALS and eight healthy individuals at Huadong Hospital during November 2017 to April 2018; meanwhile, the metabolite concentrations of human endotoxin, short-chain fatty acids (SCFA), NO(2)-N/NO(3)-N, and γ-aminobutyric acid were also evaluated by spectrophotometry methods. The correlations between intestinal microbiota and metabolite concentration were compared between the two groups using one-way analysis of variance; the relative abundance of beneficial and harmful micro-organisms in fecal samples was also analyzed. RESULTS: In general, the richness and evenness of bacterial and archaeal communities of healthy individuals were healthier than that of patients with ALS. The phylum Firmicutes/Bacteroidetes ratio, genus Methanobrevibacter showed an enhancive tendency in patients with ALS, whereas the relative abundance of beneficial micro-organisms (genera Faecalibacterium and Bacteroides) presented a significant decrease tendency in patients with ALS. In addition, the average concentrations of human endotoxin, SCFA, NO(2)-N/NO(3)-N, and γ-aminobutyric acid in patients with ALS and healthy individuals were 64.2 vs. 65.3 EU/mL, 57.5 vs. 55.3 μg/mL, 5.7 vs. 5.3 ng/mL, and 6.1 vs. 5.4 μmol/L, respectively, indicating that the digestion and metabolism functions of gastrointestinal tract of patients might decline with this disease. CONCLUSIONS: The relative abundance of beneficial and harmful micro-organisms respectively showed decrease and increase tendency in patients with ALS.
format Online
Article
Text
id pubmed-6759115
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-67591152019-10-07 Intestinal microbiota composition in patients with amyotrophic lateral sclerosis: establishment of bacterial and archaeal communities analyses Zhai, Chao-Di Zheng, Jie-Jiao An, Bing-Chen Huang, Hong-Fang Tan, Zhou-Chun Chin Med J (Engl) Original Articles BACKGROUND: Emerging evidences have indicated that the composition of gut microbiota was significantly influenced by central nervous system diseases. The digestion and metabolism disturbances of patients with amyotrophic lateral sclerosis (ALS) might be strongly associated with ALS; however, this has rarely been evaluated in these populations. This study was to evaluate bacterial and archaeal composition of gut flora and the corresponding metabolism performance of these micro-organisms in fecal samples of patients with ALS. METHODS: A comparative study was performed on the intestinal microbiota from eight patients with ALS and eight healthy individuals at Huadong Hospital during November 2017 to April 2018; meanwhile, the metabolite concentrations of human endotoxin, short-chain fatty acids (SCFA), NO(2)-N/NO(3)-N, and γ-aminobutyric acid were also evaluated by spectrophotometry methods. The correlations between intestinal microbiota and metabolite concentration were compared between the two groups using one-way analysis of variance; the relative abundance of beneficial and harmful micro-organisms in fecal samples was also analyzed. RESULTS: In general, the richness and evenness of bacterial and archaeal communities of healthy individuals were healthier than that of patients with ALS. The phylum Firmicutes/Bacteroidetes ratio, genus Methanobrevibacter showed an enhancive tendency in patients with ALS, whereas the relative abundance of beneficial micro-organisms (genera Faecalibacterium and Bacteroides) presented a significant decrease tendency in patients with ALS. In addition, the average concentrations of human endotoxin, SCFA, NO(2)-N/NO(3)-N, and γ-aminobutyric acid in patients with ALS and healthy individuals were 64.2 vs. 65.3 EU/mL, 57.5 vs. 55.3 μg/mL, 5.7 vs. 5.3 ng/mL, and 6.1 vs. 5.4 μmol/L, respectively, indicating that the digestion and metabolism functions of gastrointestinal tract of patients might decline with this disease. CONCLUSIONS: The relative abundance of beneficial and harmful micro-organisms respectively showed decrease and increase tendency in patients with ALS. Wolters Kluwer Health 2019-08-05 2019-08-05 /pmc/articles/PMC6759115/ /pubmed/31306225 http://dx.doi.org/10.1097/CM9.0000000000000351 Text en Copyright © 2019 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Original Articles
Zhai, Chao-Di
Zheng, Jie-Jiao
An, Bing-Chen
Huang, Hong-Fang
Tan, Zhou-Chun
Intestinal microbiota composition in patients with amyotrophic lateral sclerosis: establishment of bacterial and archaeal communities analyses
title Intestinal microbiota composition in patients with amyotrophic lateral sclerosis: establishment of bacterial and archaeal communities analyses
title_full Intestinal microbiota composition in patients with amyotrophic lateral sclerosis: establishment of bacterial and archaeal communities analyses
title_fullStr Intestinal microbiota composition in patients with amyotrophic lateral sclerosis: establishment of bacterial and archaeal communities analyses
title_full_unstemmed Intestinal microbiota composition in patients with amyotrophic lateral sclerosis: establishment of bacterial and archaeal communities analyses
title_short Intestinal microbiota composition in patients with amyotrophic lateral sclerosis: establishment of bacterial and archaeal communities analyses
title_sort intestinal microbiota composition in patients with amyotrophic lateral sclerosis: establishment of bacterial and archaeal communities analyses
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759115/
https://www.ncbi.nlm.nih.gov/pubmed/31306225
http://dx.doi.org/10.1097/CM9.0000000000000351
work_keys_str_mv AT zhaichaodi intestinalmicrobiotacompositioninpatientswithamyotrophiclateralsclerosisestablishmentofbacterialandarchaealcommunitiesanalyses
AT zhengjiejiao intestinalmicrobiotacompositioninpatientswithamyotrophiclateralsclerosisestablishmentofbacterialandarchaealcommunitiesanalyses
AT anbingchen intestinalmicrobiotacompositioninpatientswithamyotrophiclateralsclerosisestablishmentofbacterialandarchaealcommunitiesanalyses
AT huanghongfang intestinalmicrobiotacompositioninpatientswithamyotrophiclateralsclerosisestablishmentofbacterialandarchaealcommunitiesanalyses
AT tanzhouchun intestinalmicrobiotacompositioninpatientswithamyotrophiclateralsclerosisestablishmentofbacterialandarchaealcommunitiesanalyses